TMCO3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.27530011393173E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.53636999999929E-05 |
Normal-vs-Stage2 |
3.570000E-04 |
Normal-vs-Stage3 |
1.0790035531727E-11 |
Normal-vs-Stage4 |
7.53169970835188E-10 |
Stage1-vs-Stage2 |
5.468000E-01 |
Stage1-vs-Stage3 |
1.237730E-04 |
Stage1-vs-Stage4 |
3.434400E-04 |
Stage2-vs-Stage3 |
3.895900E-02 |
Stage2-vs-Stage4 |
3.928500E-02 |
Stage3-vs-Stage4 |
8.040800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.91589966114236E-10 |
Normal-vs-AfricanAmerican |
1.002740E-03 |
Normal-vs-Asian |
5.842000E-01 |
Caucasian-vs-AfricanAmerican |
3.650000E-01 |
Caucasian-vs-Asian |
1.399390E-01 |
AfricanAmerican-vs-Asian |
3.048400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.30580032634498E-11 |
Normal-vs-Female |
2.07870000001886E-06 |
Male-vs-Female |
7.494400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.658000E-03 |
Normal-vs-Age(41-60Yrs) |
6.90000000469482E-08 |
Normal-vs-Age(61-80Yrs) |
6.97430002638555E-10 |
Normal-vs-Age(81-100Yrs) |
4.0857999999977E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.795400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.844000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.390400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.374400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.602800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.820800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.871440E-01 |
Normal-vs-Grade 2 |
1.67819999996599E-06 |
Normal-vs-Grade 3 |
2.20459994704214E-09 |
Normal-vs-Grade 4 |
1.63857816204427E-12 |
Grade 1-vs-Grade 2 |
3.948000E-01 |
Grade 1-vs-Grade 3 |
1.637790E-01 |
Grade 1-vs-Grade 4 |
1.603390E-03 |
Grade 2-vs-Grade 3 |
4.281600E-02 |
Grade 2-vs-Grade 4 |
3.54329999996406E-06 |
Grade 3-vs-Grade 4 |
3.796200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.51661999999719E-05 |
Normal-vs-ccB subtype |
1.63629999549997E-08 |
ccA subtype-vs-ccB subtype |
1.160150E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.22489995924013E-09 |
Normal-vs-N1 |
1.602230E-01 |
N0-vs-N1 |
7.765400E-01 |
|
|